Article
SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril)-Induced Cough: a Pharmacogenetic Study.
Scientific reports - 26 Nov 2015
Luo Jian-Quan, He Fa-Zhong, Wang Zhen-Min, Sun Ning-Ling, Wang Lu-Yan, Tang Gen-Fu, Liu Mou-Ze, Li Qing, Chen Xiao-Ping, Liu Zhao-Qian, Zhou Hong-Hao, Zhang Wei
Abstract excerpt
Clinical observations suggest that incidence of cough in Chinese taking angiotensin converting enzyme inhibitors is much higher than other racial groups. Cough is the most common adverse reaction of enalapril. We investigate whether SLCO1B1 genetic polymorphisms, previously reported to be important determinants of inter-individual variability in enalapril pharmacokinetics, are associated with the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
